Adolescent Patient Education Regarding ADHD Stimulant Diversion And Misuse.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 27609322.
- Also identified by DOI 10.1016/j.pec.2016.08.023.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent studies report that adolescents misuse and divert ADHD stimulants. This study evaluates the extent to which physicians educate adolescents with ADHD about stimulant misuse and diversion (M/D). Child/adolescent psychiatrists (CAP), child neurologists (CN), and developmental-behavioral pediatricians (DBP) in the US completed a questionnaire. Descriptive statistics were performed on the final sample (n=826); multivariate regressions were performed to identify education practice differences. Only 46% and 44% of physicians educate patients "often" or "very often" on health risks and legal consequences, respectively, of stimulant M/D. CAP are more likely to educate on health and legal consequences than CN, and more likely to educate on legal consequences than DBP. Compared to physicians who prescribe stimulants to 1-10 patients (low prescribers), medium prescribers (11-30 patients) and high prescribers (30+ patients) are more likely to educate about M/D. 60% of physicians counsel patients at least "often" about M/D in a pre-college appointment; 8% have written materials regarding M/D available. Many physcians currently don't educate adolescent patients with ADHD often enough about M/D. CN and DBP, and low prescribers, are less likely to educate about M/D. Physicians who prescribe stimulants must educate patients more often to prevent stimulant M/D.
Medical subject headings
- Attention Deficit Disorder with Hyperactivity
- Central Nervous System Stimulants
- Patient Education as Topic
- Prescription Drug Diversion
- Prescription Drug Misuse
- Prescription Drugs